Still a hopeless case for personalized oncology? Pancreatic cancer revisited
نویسندگان
چکیده
منابع مشابه
pharmacogenetics and personalized medicine in pancreatic cancer
pancreatic cancer (pc) is a progressive, fatal disease with a high degree of malignancy. more than 40000 peoplediefrom this cancer annually in the united states. as a multifactorial condition, pc has a complex nature, and there are several genes and signalingpathwaysimplicated in pc pathogenesis and progression. there are diffèrent mutations in master genesincludingtumorsuppressors and oncogene...
متن کاملA . Meyrier ) A hopeless case ?
End-stage renal failure in an octogenarian with advanced congestive heart failure is a daunting challenge for the physician. Many of these patients cannot tolerate haemodialysis, due to severely impaired left-ventricular function, valvular disease or both. In such patients, peritoneal dialysis may be the only feasible option but home therapy is often impossible, due to age, comorbidity and lack...
متن کاملPersonalized RNA Medicine for Pancreatic Cancer.
Purpose: Since drug responses vary between patients, it is crucial to develop pre-clinical or co-clinical strategies that forecast patient response. In this study, we tested whether RNA-based therapeutics were suitable for personalized medicine by using patient-derived-organoid (PDO) and patient-derived-xenograft (PDX) models.Experimental Design: We performed microRNA (miRNA) profiling of PDX s...
متن کاملMatching Cancer Genomes to Established Cell Lines for Personalized Oncology
The diagnosis and treatment of cancers, which rank among the leading causes of mortality in developed nations, presents substantial clinical challenges. The genetic and epigenetic heterogeneity of tumors can lead to differential response to therapy and gross disparities in patient outcomes, even for tumors originating from similar tissues. High-throughput DNA sequencing technologies hold promis...
متن کاملPANCREATIC SCHWANNOMA: A CASE REPORT
Schwannomas may occur anywhere in the soft tissues or viscera, but do not commonly involve the pancreas and retroperitoneum. We present a case of benign pancreatic schwannoma which clinically simulated a malignant neoplastic process.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncoscience
سال: 2018
ISSN: 2331-4737
DOI: 10.18632/oncoscience.464